科研之友
微信
新浪微博
Facebook
分享链接
摘要
Background: The mevalonate pathway is an important metabolic pathway that plays a key role in multiple cellular processes. The aim of this study was to define whether the enzyme expression in mevalonate pathway changes during cardiovascular remodelling in spontaneously hypertensive rats (SHR). Methods and Results: Hearts and thoracic aortas were removed for the study of cardiovascular remodeling in SHR and Wistar-Kyoto rats (WKY). The protein expression of the enzymes in hearts, aortas and livers was analyzed by western blot. The histological measurements showed that the mass and the size of cardiomyocytes, the media thickness and the media cross-sectional area (MCSA) of the thoracic aorta were all increased in SHR since 3 weeks of age. In the heart, there was overexpression of some enzymes, including 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR), farnesyl diphosphate synthase (FDPS), and geranylgeranyltransferase type I (GGTase-I), and downregulation of squalene synthetase (SOS) in SHR since 3 weeks of age. In the aorta, besides similar expressions of HMGR, SOS, FDPS and GGTase-I as in the heart, there was upregulation of farnesyltransferase alpha at 16 and 25 weeks of age and of farnesyltransferase beta in 25-weeks-old SHR. Western blot demonstrated overexpression of HMGR and downregulation of SOS in SHR livers at all ages tested. Conclusions: The cardiovascular remodeling of SHR preceded the development of hypertension, and altered expression of several key enzymes in the mevalonate pathway may play a potential pathophysiological role in cardiovascular remodeling. (Circ J 2011; 75: 1409-1417)
- 出版日期2011-6
- 单位浙江大学
